Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CO › Englewood › NPI 1598747651
Lab

Laboratory Corporation of America

Laboratory Corporation of America was paid $77.80M by Medicaid between Jan 2018 and Dec 2024, across 275 billing codes. Its largest line is 80050, General health panel — 14% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA
ENGLEWOOD, CO 80112
33aNPI1598747651assigned 11/15/2005
33bProvider typeClinical Medical Laboratory
28Total paid$77.80M
24GClaims6,373,382
24DCodes billed275
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Colorado

Rank by total paid#1 of 91
Median peer was paid$53K
This provider vs. median1,463×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018790,301$10.82M
2019918,068$11.66M
2020825,234$9.73M
2021937,902$11.63M
2022943,970$11.43M
20231,079,740$12.58M
2024incomplete878,167$9.95M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80050 General health panel 14% 269,252 254,405 $10.57M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 7.9% 232,026 216,340 $6.17M
80061 Lipid panel 6.9% 442,208 413,640 $5.40M
84443 Thyroid stimulating hormone (TSH) 5.6% 290,062 267,734 $4.35M
80053 Comprehensive metabolic panel 4.9% 402,695 361,546 $3.79M
83036 Hemoglobin; glycosylated (A1C) 4.4% 384,235 358,463 $3.41M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.3% 412,604 351,517 $2.58M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 3.1% 121,680 114,162 $2.45M
87086 Culture, bacterial; quantitative colony count, urine 2.4% 252,595 228,822 $1.88M
80081 2.2% 28,949 27,088 $1.71M
80074 2.0% 34,215 31,841 $1.54M
82607 1.9% 105,423 97,812 $1.46M
263 more codes
86803 1.9% 113,326 $1.45M
84439 1.7% 165,678 $1.33M
82728 1.5% 93,797 $1.16M
84403 1.4% 47,003 $1.11M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 1.4% 2,228 $1.07M
86480 1.2% 16,243 $897K
82746 1.0% 58,339 $783K
84481 1.0% 49,824 $781K
87186 <1% 90,681 $758K
82670 <1% 29,574 $756K
84153 <1% 41,523 $704K
87088 <1% 90,728 $666K
87150 <1% 19,948 $639K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 30,079 $635K
83550 <1% 77,268 $618K
87081 <1% 99,060 $602K
80048 Basic metabolic panel (calcium, ionized) <1% 76,158 $578K
83970 <1% 15,604 $567K
85027 <1% 104,220 $566K
83001 <1% 32,678 $561K
87340 <1% 57,846 $542K
84402 <1% 22,379 $521K
83540 <1% 89,706 $517K
84702 <1% 33,825 $468K
84146 <1% 23,352 $419K
87077 <1% 56,990 $406K
86140 <1% 80,644 $389K
83002 <1% 21,860 $378K
87070 <1% 41,878 $338K
86592 <1% 85,456 $326K
84144 <1% 18,042 $324K
86762 <1% 23,467 $315K
82570 <1% 68,223 $312K
82784 <1% 22,178 $275K
84436 <1% 42,542 $274K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 9,781 $262K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 9,714 $258K
82043 <1% 49,336 $252K
86706 <1% 26,011 $245K
86376 <1% 17,890 $226K
86677 <1% 6,826 $225K
80076 <1% 30,890 $224K
86850 <1% 26,820 $211K
86704 <1% 19,862 $210K
81001 <1% 70,198 $205K
83735 <1% 33,719 $201K
83880 <1% 6,081 $198K
82950 <1% 42,697 $197K
84480 <1% 14,677 $195K
86769 <1% 4,362 $188K
82627 <1% 8,209 $167K
83690 <1% 24,614 $159K
85652 <1% 62,862 $159K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,823 $151K
84479 <1% 23,076 $144K
84460 <1% 32,754 $140K
86780 <1% 11,935 $140K
84550 <1% 34,262 $136K
86431 <1% 24,912 $134K
86787 <1% 11,343 $132K
86708 <1% 11,802 $129K
82565 <1% 30,163 $118K
85610 <1% 30,296 $115K
82105 <1% 7,432 $111K
84450 <1% 28,457 $110K
82533 <1% 7,042 $109K
86360 <1% 2,669 $102K
86696 <1% 5,611 $99K
87075 <1% 11,797 $96K
80069 <1% 12,920 $94K
86364 <1% 5,920 $92K
82248 <1% 20,799 $89K
82977 <1% 15,940 $87K
82247 <1% 23,745 $85K
84156 <1% 25,096 $83K
86141 <1% 6,636 $81K
82550 <1% 12,743 $80K
84100 <1% 20,567 $78K
82150 <1% 12,476 $77K
86317 <1% 4,810 $77K
80164 <1% 6,880 $75K
83615 <1% 16,217 $75K
82951 <1% 7,747 $75K
86901 <1% 24,155 $73K
83525 <1% 6,905 $70K
86146 <1% 1,995 $70K
85730 <1% 13,579 $69K
86800 <1% 4,929 $68K
86900 <1% 24,222 $67K
83090 <1% 4,378 $67K
84520 <1% 20,424 $65K
84681 <1% 3,563 $65K
84270 <1% 3,334 $64K
82947 <1% 18,529 $62K
86695 <1% 5,315 $62K
82040 <1% 17,368 $60K
86147 <1% 2,161 $57K
86709 <1% 5,536 $56K
86361 <1% 2,626 $56K
82024 <1% 1,984 $56K
82310 <1% 16,236 $56K
86038 <1% 5,573 $55K
83721 <1% 6,093 $54K
86304 <1% 2,780 $54K
84155 <1% 17,998 $54K
84075 <1% 15,911 $53K
86160 <1% 2,501 $53K
84154 <1% 3,100 $53K
82785 <1% 3,399 $52K
86235 <1% 590 $50K
86735 <1% 4,312 $50K
36415 Collection of venous blood by venipuncture <1% 44,043 $50K
86765 <1% 4,313 $49K
83516 <1% 1,765 $49K
84165 <1% 4,956 $47K
82378 <1% 2,584 $45K
80178 <1% 8,042 $44K
84703 <1% 6,574 $44K
86200 <1% 4,160 $44K
82787 <1% 1,859 $44K
84295 <1% 13,701 $43K
86705 <1% 3,866 $41K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,378 $41K
80055 <1% 1,469 $41K
82435 <1% 13,368 $41K
84134 <1% 3,522 $38K
87427 <1% 3,042 $37K
87324 <1% 3,251 $37K
84466 <1% 3,459 $36K
86702 <1% 3,024 $35K
84132 <1% 9,940 $34K
86359 <1% 1,184 $31K
82140 <1% 2,358 $29K
83718 <1% 3,877 $29K
87045 <1% 3,040 $29K
87493 <1% 854 $27K
86701 <1% 3,003 $27K
83521 <1% 1,153 $26K
82952 <1% 6,756 $26K
86003 <1% 315 $24K
82465 <1% 6,166 $23K
85379 <1% 2,645 $23K
80051 <1% 3,768 $23K
81003 <1% 11,110 $22K
86300 <1% 1,101 $22K
86593 <1% 5,457 $22K
84478 <1% 4,728 $22K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 864 $21K
85045 <1% 4,925 $20K
86334 <1% 1,186 $19K
86258 <1% 2,436 $19K
87076 <1% 2,676 $18K
80156 <1% 1,452 $17K
85598 <1% 2,015 $17K
86060 <1% 2,694 $17K
87522 Neg quan hep c or qual rna <1% 592 $17K
85018 <1% 7,154 $15K
82374 <1% 5,169 $15K
80159 <1% 1,322 $15K
82390 <1% 1,646 $15K
86355 <1% 565 $15K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 68 $14K
87205 <1% 3,230 $13K
87046 <1% 3,059 $13K
86308 <1% 2,612 $13K
85613 <1% 2,153 $13K
87350 <1% 1,178 $12K
81241 <1% 452 $12K
82652 <1% 441 $12K
86707 <1% 1,173 $12K
87184 <1% 1,722 $12K
83921 <1% 650 $11K
82172 <1% 570 $10K
85014 <1% 4,512 $10K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 998 $9K
84207 <1% 388 $9K
83883 <1% 1,139 $9K
82672 <1% 476 $8K
81025 <1% 1,133 $8K
80185 <1% 661 $8K
83014 <1% 1,105 $8K
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 1,156 $8K
87210 <1% 2,033 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 247 $7K
85597 <1% 815 $7K
85240 <1% 738 $7K
80321 <1% 458 $7K
80349 <1% 518 $7K
86357 <1% 237 $6K
84482 <1% 511 $6K
86301 <1% 332 $6K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 270 $6K
85007 <1% 2,162 $6K
86225 <1% 518 $5K
87040 <1% 424 $5K
84166 <1% 332 $5K
84630 <1% 516 $4K
85246 <1% 396 $4K
85670 <1% 1,242 $4K
81240 <1% 198 $4K
80361 <1% 272 $4K
85245 <1% 406 $4K
86804 <1% 226 $4K
82525 <1% 363 $4K
84425 <1% 237 $3K
83013 <1% 61 $3K
84484 <1% 372 $3K
85660 <1% 637 $3K
80365 <1% 214 $3K
83520 <1% 154 $3K
82553 <1% 227 $3K
82340 <1% 414 $2K
83655 <1% 221 $2K
36416 <1% 1,510 $2K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 424 $2K
87480 <1% 113 $2K
87510 <1% 113 $2K
87660 <1% 113 $2K
86618 <1% 114 $2K
83010 <1% 162 $2K
80165 <1% 164 $2K
85384 <1% 163 $1K
86356 <1% 26 $1K
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 2,999 $1K
81015 <1% 345 $974.46
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 325 $937.51
80356 <1% 54 $868.70
84446 <1% 67 $856.62
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 86 $812.16
99199 Unlisted special service, procedure or report <1% 29 $718.83
84300 <1% 152 $705.52
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 50 $573.60
80324 <1% 31 $495.32
86880 <1% 161 $488.95
82610 <1% 33 $477.25
85335 <1% 39 $403.20
80177 <1% 51 $326.12
85049 <1% 66 $322.64
84080 <1% 27 $302.96
82103 <1% 25 $259.21
86665 <1% 13 $252.20
85048 <1% 122 $241.38
82575 <1% 25 $235.42
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 27 $210.58
80358 <1% 27 $178.97
80347 <1% 27 $172.93
86777 <1% 16 $172.25
80373 <1% 27 $170.34
80348 <1% 27 $169.77
80354 <1% 27 $169.15
80353 <1% 27 $169.10
80359 <1% 27 $168.25
80372 <1% 27 $167.90
85247 <1% 12 $126.35
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 14 $125.40
82330 <1% 12 $122.32
82180 <1% 12 $116.88
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 14 $116.40
80175 <1% 14 $94.60
89060 <1% 12 $87.12
85303 <1% 14 $76.40
81500 <1% 13 $52.10
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 44 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.